Dr. Harry Demopoulos, MD, former associate professor of pathology at the New York University School of Medicine will be at Expo West to discuss how Setria brand glutathione has been proven to be absorbed orally in animal and human clinical dosing studies. The event is sponsored by Kyowa Hakko USA (New York City). Glutathione is a tri-peptide made up of glutamic acid, cysteine, and glycine. It is believed to increase the effectiveness of antioxidants like vitamin C and E, and help protect the body from free radicals and other harmful compounds.
Dr. Harry Demopoulos, MD, former associate professor of pathology at the New York University School of Medicine will be at Expo West to discuss how Setria brand glutathione has been proven to be absorbed orally in animal and human clinical dosing studies. The event is sponsored by Kyowa Hakko USA (New York City).
Glutathione is a tri-peptide made up of glutamic acid, cysteine, and glycine. It is believed to increase the effectiveness of antioxidants like vitamin C and E, and help protect the body from free radicals and other harmful compounds.
Demopoulos... presentation will be held at Expo West on Saturday, March 13, from 2 to 3 p.m. in room 205A. Visitors will also be able to meet with Kyowa Hakko customers and receive complimentary Setria products. Demopoulos is a recipient of the Research Career Development Award from the National Cancer Institute.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.